Pancreatic Cancer Drug Market Pipeline Analysis Study


Dallas, TX -- (ReleaseWire) -- 03/31/2014 -- "Pancreatic Cancer Drug Pipeline Analysis" by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Pancreatic Cancer. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each drug profile in development phase enables the reader to identify and understand the therapeutics associated with the Pancreatic Cancer disease. The information for particular drug in development process is represented in the form of tables and detailed analysis including the available Pharmacodynamics and Pharmacokinetics results.

Inquire for a discount on this report @

This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the drug development process. Report also helps drug development organisation to keep track record the ongoing drug profiles being developed by their key competitor in the industry.

Buy a copy of this report @

Following parameters for each drug profile in development phase are covered in "Pancreatic Cancer Drug Pipeline Analysis" research report:
Drug Profile Overview
Active Indication
Phase of Development
Country for Clinical Trial
Owner / Originator/ Licensee/Collaborator
Administrative Route
Drug Class
Patent Information
Molecular Formula
Brand Names
Development Agreements
ATC Codes

Complete report available @

Contact for further information.